Impact of the CYP2C8 3 polymorphism on the drug–drug interaction between gemfibrozil and pioglitazone by Aquilante, Christina L., Kosmiski, Lisa A., Bourne, David W. A., Bushman, Lane R., Daily, Elizabeth B., Hammond, Kyle P., Hopley, Charles W., Kadam, Rajendra S., Kanack, Alexander T., Kompella, Uday B., Le, Merry, Predhomme, Julie A., Rower, Joseph E., Sidhom, Maha S.

Get full text

Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease by Vu, Anh, Sidhom, Maha S, Bredbeck, Brooke C, Kosmiski, Lisa A, Aquilante, Christina L

Get full text

Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus by Vu, Anh, Kosmiski, Lisa A., Beitelshees, Amber L., Prigeon, Ronald, Sidhom, Maha S., Bredbeck, Brooke, Predhomme, Julie, Deininger, Kimberly M., Aquilante, Christina L.

Get full text

Influence of CYP2C82 on the Pharmacokinetics of Pioglitazone in Healthy African-American Volunteers by Aquilante, Christina L., Wempe, Michael F., Spencer, Samantha H., Kosmiski, Lisa A., Predhomme, Julie A., Sidhom, Maha S.

Get full text

Effect of ABCB1 polymorphisms and atorvastatin on sitagliptin pharmacokinetics in healthy volunteers by Aquilante, Christina L., Wempe, Michael F., Sidhom, Maha S., Kosmiski, Lisa A., Predhomme, Julie A.

Get full text

Influence of SLCO1B1 Polymorphisms on the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin by Aquilante, Christina L., Kiser, Jennifer J., Anderson, Peter L., Christians, Uwe, Kosmiski, Lisa A., Daily, Elizabeth B., Hoffman, Keith L., Hopley, Charles W., Predhomme, Julie A., Schniedewind, Bjorn, Sidhom, Maha S.

Get full text